AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
This guide compares region-focused ETFs to highlight which region pays the highest dividend and what factors influence payouts.
21,913 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Wix has endured a brutal stock down year, dropping roughly 70% as growth worries and macro headwinds hit software nam...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
April CPI-W data shows 3.9% inflation, lifting 2027 COLA forecasts and reshaping retirement planning as fixed-income ...
Markets paused their march higher at midday as tech leadership shines and geopolitical headwinds test appetite. Marve...
Two Harbors Investment Corp. shareholders approved an all-cash sale to CCM at $12 per share, ending a months-long bid...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...
When a single stock moves sharply, it can feel like a loud warning bell. This article explains why intel stock slumpe...
Markets feel loud, but a few steady ideas can anchor decisions. Here are five things thinking about markets that blen...
The Dow Jones Industrial Average surged to a new record as investors rotated into value stocks while technology wobbl...
Ford's fourth quarter shocked many investors: a massive net loss despite solid revenue. This article peels back the d...